FGEN
Price:
$9.07
Market Cap:
$28.86M
FibroGen, Inc. is a biopharmaceutical firm dedicated to discovering, developing, and bringing to market therapies that address significant medical conditions currently lacking effective treatments. Among its pipeline, FibroGen is advancing Roxadustat, an orally administered small molecule that inhibits hypoxia inducible factor prolyl hydroxylases. This drug has successfully completed Phase III clinical trials in the US, Europe, China, and Japan for treating anemia in chronic kidney disease, and is currently in Phase II/III development in China for anemia linked to myelodysplastic syndromes. Additionally, the company is progressing Pamrevlumab, a human monoclonal antibody designed to block co...[Read more]
Industry
Biotechnology
IPO Date
2014-11-14
Stock Exchange
NASDAQ
Ticker
FGEN
According to FibroGen, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 11.12M. This represents a change of 104.80% compared to the average of 5.43M of the last 4 quarters.
The mean historical Enterprise Value of FibroGen, Inc. over the last ten years is 46.57B. The current 11.12M Enterprise Value has changed -97.61% with respect to the historical average. Over the past ten years (40 quarters), FGEN's Enterprise Value was at its highest in in the June 2018 quarter at 130.36B. The Enterprise Value was at its lowest in in the September 2025 quarter at -47396000.00.
Average
46.57B
Median
35.45B
Minimum
73.17M
Maximum
97.27B
Discovering the peaks and valleys of FibroGen, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 156.52%
Maximum Annual Enterprise Value = 97.27B
Minimum Annual Increase = -94.64%
Minimum Annual Enterprise Value = 73.17M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 73.17M | -94.64% |
| 2024 | 1.36B | -38.35% |
| 2023 | 2.21B | -94.09% |
| 2022 | 37.41B | 15.18% |
| 2021 | 32.48B | -60.71% |
| 2020 | 82.68B | -10.92% |
| 2019 | 92.82B | -4.57% |
| 2018 | 97.27B | 13.22% |
| 2017 | 85.91B | 156.52% |
| 2016 | 33.49B | -27.04% |
The current Enterprise Value of FibroGen, Inc. (FGEN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.22B
5-year avg
14.71B
10-year avg
46.57B
FibroGen, Inc.’s Enterprise Value is greater than Kezar Life Sciences, Inc. (-11018667.00), less than Tempest Therapeutics, Inc. (11.64M), greater than Aligos Therapeutics, Inc. (6.87M), greater than OnKure Therapeutics, Inc. (-134267880.00), less than Mersana Therapeutics, Inc. (91.27M), less than X4 Pharmaceuticals, Inc. (161.10M), less than PDS Biotechnology Corporation (52.81M), less than Celularity Inc. (51.87M), greater than Xilio Therapeutics, Inc. (-89055595.00), greater than Actinium Pharmaceuticals, Inc. (-8924256.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -11018667.00 | $53.86M | |
| 11.64M | $5.60M | |
| 6.87M | $32.67M | |
| -134267880.00 | $57.43M | |
| 91.27M | $145.36M | |
| 161.10M | $377.28M | |
| 52.81M | $58.61M | |
| 51.87M | $17.15M | |
| -89055595.00 | $54.64M | |
| -8924256.00 | $31.69M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like FibroGen, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like FibroGen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is FibroGen, Inc.'s Enterprise Value?
What is the highest Enterprise Value for FibroGen, Inc. (FGEN)?
What is the 3-year average Enterprise Value for FibroGen, Inc. (FGEN)?
What is the 5-year average Enterprise Value for FibroGen, Inc. (FGEN)?
How does the current Enterprise Value for FibroGen, Inc. (FGEN) compare to its historical average?